series-a
Stage
1
Investors
About
Reprise Biomedical develops biologic medical devices using proprietary perfusion decellularization technology to create collagen scaffolds that facilitate rapid cellular integration and healing of deep and tunneling wounds.
Explore Reprise Biomedical's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.